| Bioactivity | Ac9-25, a N-terminal peptide of Annexin I, acts as a formyl peptide receptor (FPR) agonist and activates the neutrophil NADPH oxidase through FPR[1][2]. | ||||||
| Name | Ac9-25 | ||||||
| CAS | 284040-76-2 | ||||||
| Sequence | Ac-Gln-Ala-Trp-Phe-Ile-Glu-Asn-Glu-Glu-Gln-Glu-Tyr-Val-Gln-Thr-Val-Lys | ||||||
| Shortening | Ac-QAWFIENEEQEYVQTVK | ||||||
| Formula | C99H143N23O33 | ||||||
| Molar Mass | 2183.33 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
Ac9-25
CAS: 284040-76-2 F: C99H143N23O33 W: 2183.33
Ac9-25, a N-terminal peptide of Annexin I, acts as a formyl peptide receptor (FPR) agonist and activates the neutrophil
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.